Nexomics Biosciences logo

Nexomics Biosciences

Nexomics offers comprehensive range of gene-to- structure services to the biopharmaceutical community.

10 employees · est. 2007 · Rocky Hill, United States

VS
Vernalis logo

Vernalis

We develop and apply fragment and structure-based methods to solve problems in drug discovery

253 employees · est. 1997 · Cambridge, United Kingdom

Vernalis is the older company (2007 vs 1997); Vernalis is the larger of the two.

Side-by-Side Comparison

Nexomics Biosciences Vernalis
Founded
2007 1997 older
Headquarters
Rocky Hill, United States Cambridge, United Kingdom
Employees
10 253 larger
Industry
Biopharma, Biotechnology, Clean Energy Biotechnology, Pharmaceutical
Funding Stage
Not tracked yet Series Unknown
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
Not tracked yet 1
Services
Not tracked yet Drug Discovery Collaboration, Protein Production, Hit Identification and Validation, Lead Optimization, Biophysics and Structural Biology, Chemical Series Evolution
Target Customers
Not tracked yet Pharmaceutical Companies, Biotech Firms, Research Institutions, Drug Discovery Teams
Taxonomy
Biopharmaceutical Research, Gene-to-structure Services, Drug Discovery, Protein Production, Assay Development, Bioinformatics Analysis Fragment-based Drug Discovery, Structure-based Methods, Oncology Drug Discovery, Neurodegeneration Targets, Anti-infectives, Inflammation Drug Discovery, Structural Biology, Biophysics, Medicinal Chemistry, Molecular Modelling, Protein-protein Interactions, Development Of Clinical Candidates, Kinases And ATPases, GPCRs, Shared-risk Research Collaborations
Website
nexomics.com vernalis.com
Nexomics Biosciences logo

About Nexomics Biosciences

Nexomics Biosciences is a biopharmaceutical company established in 2007 with a focus on the discovery, development, and commercialization of novel drugs in the areas of cancer, antiviral, and antibiotic treatments. The company operates as a contract research organization (CRO), offering a wide range...

Vernalis logo

About Vernalis

Vernalis, founded in 1997, is a UK-based company operating at the forefront of the Biotechnology and Pharmaceutical industries. With a commitment to advancing drug discovery, their slogan encapsulates their mission: "We develop and apply fragment and structure-based methods to solve problems in drug...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Nexomics Biosciences and Vernalis — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Nexomics Biosciences and Vernalis — by email.

Frequently Asked Questions

Nexomics Biosciences — Nexomics offers comprehensive range of gene-to- structure services to the biopharmaceutical community. . Vernalis — We develop and apply fragment and structure-based methods to solve problems in drug discovery. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Nexomics Biosciences and Vernalis operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Nexomics Biosciences with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy